| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 06/27/2013 | WO2013092711A1 Trpm8 antagonists |
| 06/27/2013 | WO2013066134A3 Novel cinnamyl-rhodanine derivatives and pharmaceutical composition comprising same as active ingredients |
| 06/27/2013 | WO2013053034A3 Thiazacridines used in anti-cancer therapy |
| 06/27/2013 | US20130165662 Preparation of febuxostat |
| 06/27/2013 | US20130165443 Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists |
| 06/26/2013 | EP2607357A1 Benzothiazoles as ghrelin receptor modulators |
| 06/26/2013 | EP2606888A1 Trpm8 antagonists |
| 06/26/2013 | EP2606036A1 New compounds |
| 06/26/2013 | CN203018092U Device for synthesising accelerant CBS via oxygen oxidation process |
| 06/26/2013 | CN103180304A Novel synthesis for thiazolidinedione compounds |
| 06/26/2013 | CN103180291A Alkoxyimino derivative and pest control agent |
| 06/26/2013 | CN103172590A Squaraines chemical sensor for colorimetrically identifying Fe and Cu ion and preparation method thereof |
| 06/26/2013 | CN103172589A Thiazolyl-dihydroquinazolines |
| 06/26/2013 | CN103172569A 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms |
| 06/26/2013 | CN103172523A Method for realizing selective N-methylation of primary amine |
| 06/26/2013 | CN101481613B Electroluminescent organic material based on benzothiazolyl |
| 06/25/2013 | US8470855 Dual-use peptidase inhibitors as prodrugs for a therapy of inflammatory and other diseases |
| 06/25/2013 | US8470829 Imidazolidine derivative and use thereof |
| 06/20/2013 | WO2013090454A2 Novel glp-1 receptor modulators |
| 06/20/2013 | WO2013088449A1 Stable crystal form of febuxostat and process for the preparation thereof |
| 06/20/2013 | US20130158272 Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using palladium compound |
| 06/20/2013 | US20130158082 Methods of managing blood sugar levels and compositions related thereto |
| 06/20/2013 | US20130158075 Heterocyclic compounds as dgat1 inhibitors |
| 06/20/2013 | CA2857197A1 Novel glp-1 receptor modulators |
| 06/19/2013 | EP2603498A1 Novel synthesis for thiazolidinedione compounds |
| 06/19/2013 | CN103168028A Cyclic amide derivative |
| 06/19/2013 | CN103159697A Method for preparing nitazoxanide |
| 06/19/2013 | CN103159696A Preparation and bactericidal activity of N-phenyl-substituted thiazole methanamide compounds |
| 06/19/2013 | CN103159695A Thiazole compound capable of restraining human immunodeficiency virus (HIV) replication and effective against drug-resistant HIV virus strains and preparation method and purpose thereof |
| 06/19/2013 | CN103159691A Preparing method and application of isothiocyanate compound |
| 06/19/2013 | CN103159686A HIV-1 protease urea inhibitor |
| 06/19/2013 | CN103159674A 2-benzene alkyl amid compound and preparation method, medical composition and use thereof |
| 06/19/2013 | CN102285937B Method for synthesizing febuxostat |
| 06/19/2013 | CN102181277B Corrosion inhibitor for controlling corrosion of high-concentration hydrogen sulfide in acid liquor medium and preparation method thereof |
| 06/19/2013 | CN102010384B Deuterated cyanophenyl thiazoles derivative for treating gout and hyperur icemia |
| 06/19/2013 | CN102002018B (2-oxo-benzothiazole)-3-diacetyl hydrazone compound as well as preparation method and application thereof |
| 06/18/2013 | US8466177 Treating and preventing viral infections |
| 06/18/2013 | CA2566212C Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives |
| 06/13/2013 | WO2013086312A1 Oral formulations for treating metal overload |
| 06/13/2013 | WO2013086229A1 Bicyclic aryl and heteroaryl sodium channel inhibitors |
| 06/13/2013 | WO2013084013A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists |
| 06/13/2013 | WO2013083024A1 Benzothiazole compound, intermediate, preparation method and use thereof |
| 06/13/2013 | US20130150416 Glutamate receptor modulators and therapeutic agents |
| 06/13/2013 | US20130150392 Iminopropene compound and use thereof |
| 06/13/2013 | CA2857990A1 Oral formulations for treating metal overload |
| 06/13/2013 | CA2857198A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists |
| 06/12/2013 | EP2601950A1 Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists |
| 06/12/2013 | CN103153972A Novel synthesis for thiazolidinedione compounds |
| 06/12/2013 | CN103153970A Oxazole And Thiazole Compounds As Ksp Inhibitors |
| 06/12/2013 | CN103145643A Aminothiazole compound dehydration and alkylation method |
| 06/12/2013 | CN103145642A Refining method of mercaptobenzothiazole disulfide |
| 06/12/2013 | CN103145641A Preparation method of 2-acyl benzothiazole derivative |
| 06/12/2013 | CN103145640A Biphenyl-thiazolo-carboxamides |
| 06/12/2013 | CN103145639A Preparation method for 2-methyl-4-(trifluoromethyl)thiazole-5-formyl acid |
| 06/12/2013 | CN101684106B Thiazole onium salt compound and application for treating diseases relative to protein aging thereof |
| 06/12/2013 | CN101445422B Organic electroluminescent material and application thereof |
| 06/12/2013 | CN101273013B Sulfonamide derivative having PGD2 receptor antagonistic activity |
| 06/11/2013 | US8461349 Fungicidal active substance combinations containing trifloxystrobin |
| 06/11/2013 | US8461348 Heterocyclic derivative and use thereof |
| 06/11/2013 | CA2683826C Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
| 06/11/2013 | CA2577837C Diarylsulfones as 5-ht2a antagonists |
| 06/11/2013 | CA2546101C N-acylsulfonamide apoptosis promoters |
| 06/06/2013 | WO2013079578A1 Production of 18f- labelled compounds comprising hydrolytic deprotection step and solid phase extraction |
| 06/06/2013 | WO2011117034A3 Cosmetic or dermatological preparations with a content of one or more thiazole derivatives |
| 06/06/2013 | US20130143927 Compounds that modulate intracellular calcium |
| 06/06/2013 | US20130143765 Inhibitors of calcium-activated chloride channels |
| 06/06/2013 | US20130142758 Novel hydroxamates as therapeutic agents |
| 06/06/2013 | CA2856457A1 Production of 18f- labelled compounds comprising hydrolytic deprotection step and solid phase extraction |
| 06/05/2013 | EP2598494A1 Improved process for the preparation of febuxostat |
| 06/05/2013 | EP2598482A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use |
| 06/05/2013 | EP2598480A1 Cyclopropylamine derivatives useful as lsd1 inhibitors |
| 06/05/2013 | CN103130792A 2-aminothiazoles compound |
| 06/05/2013 | CN103130791A Novel benzamides compound |
| 06/05/2013 | CN103130745A Diaryl-piperazines compound and medical application thereof |
| 06/05/2013 | CN103130741A Organic semiconductor material containing naphthyl anthracene and preparation method and application thereof |
| 06/05/2013 | CN103130740A Amino acid derivatives of seedvax and application for being used as bactericides thereof |
| 06/05/2013 | CN103130739A Compounds having thrombopoietin receptor agonism |
| 06/05/2013 | CN102070557B Aminothiazole alkyl xanthate derivative as well as preparation method and application of aminothiazole alkyl xanthate derivative |
| 06/04/2013 | US8455658 Thiazole and thiadiazole compounds for inflammation and immune-related uses |
| 06/04/2013 | US8455499 Alkyne antagonists of lysophosphatidic acid receptors |
| 05/30/2013 | WO2013078145A1 Biomarkers for cancers responsive to modulators of hec1 activity |
| 05/30/2013 | WO2013076738A2 Process for the preparation of febuxostat polymorphs |
| 05/30/2013 | WO2013076227A1 Novel heterocyclic alkanol-derivatives |
| 05/30/2013 | US20130137734 Polymorphs of an Active Pharmaceutical Ingredient |
| 05/30/2013 | US20130136794 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof |
| 05/30/2013 | CA2856711A1 Novel heterocyclic alkanol-derivatives |
| 05/30/2013 | CA2855923A1 Process for the preparation of febuxostat polymorphs |
| 05/29/2013 | EP2597089A1 Tricyclic heterocyclic compounds |
| 05/29/2013 | EP2595959A1 Sulfonyl compounds which modulate the cb2 receptor |
| 05/29/2013 | CN103124724A Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use |
| 05/29/2013 | CN102008459B Antibacterial agents |
| 05/29/2013 | CN101863855B Preparation of temperature sensitive acidic ionic liquid and method of using the same in catalyzing alcoholic acid esterification |
| 05/29/2013 | CN101835765B Alkylsulfonyl-substituted thiazolide compounds |
| 05/29/2013 | CN101696221B Substituted isoxazoles as fungicides |
| 05/29/2013 | CN101490023B Modulators of pharmacokinetic properties of therapeutics |
| 05/28/2013 | US8450352 Thiazole compounds and their use for inhibiting phosphodiesterase 4, TNF-α, and IL-4 |
| 05/28/2013 | US8450333 Molecules for regulating cell death |
| 05/28/2013 | US8450245 Heterocyclic alkanol derivatives |
| 05/28/2013 | US8449936 Flavor molecules |
| 05/28/2013 | CA2739883C Cyclohexane derivative and pharmaceutical use thereof |